How many email patterns does Plus Therapeutics, Inc. use?

Plus Therapeutics, Inc. uses 2 known email patterns.

What domain does Plus Therapeutics, Inc. use for work emails?

Plus Therapeutics, Inc. uses plustherapeutics.com for work email addresses.

Most Common Email Formats at Plus Therapeutics, Inc.

The most accurate and popular Plus Therapeutics, Inc.'s email format is FLast@plustherapeutics.com (ex. JDoe@plustherapeutics.com). Plus Therapeutics, Inc. also uses First.Last@plustherapeutics.com (ex. John.Doe@plustherapeutics.com) as email structures. Plus Therapeutics, Inc. uses up to 2 different email patterns.

Plus Therapeutics, Inc. Email Formats	Example	Percentage
FLast@plustherapeutics.com	JDoe@plustherapeutics.com	97%
First.Last@plustherapeutics.com	John.Doe@plustherapeutics.com	3%

Plus Therapeutics, Inc. Email Formats

Example

Percentage

FLast@plustherapeutics.com

JDoe@plustherapeutics.com

97%

First.Last@plustherapeutics.com

John.Doe@plustherapeutics.com

Frequently Asked Questions

What does Plus Therapeutics, Inc. do?

Plus Therapeutics, Inc. was founded in 2019. operates in the Pharmaceutical Manufacturing industry, along with similar companies like RocheSanofiJohnson & Johnson. You can visit plustherapeutics.com. Explore Plus Therapeutics, Inc.'s company overview page for more information.

What is Plus Therapeutics, Inc.'s email address format?

Plus Therapeutics, Inc.'s email format typically follows the pattern of FLast@plustherapeutics.com; this email format is used 97% of the time. Other contacts within LeadIQ's database had email formats such as First.Last@plustherapeutics.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Plus Therapeutics, Inc. have currently?

Plus Therapeutics, Inc. has approximately 28 employees as of July 2026. Key team members to contact include Office Manager: B. B.Senior Clinical Trial Associate: F. G.Senior Clinical Research Associate: O. L.. For more team information and contact data, explore Plus Therapeutics, Inc.'s employee directory with LeadIQ.

Plus Therapeutics, Inc. Email Format

Pharmaceutical ManufacturingTexas, United States11-50 Employees

Plus Therapeutics, Inc. is a U.S.-based clinical-stage pharmaceutical company focused on developing targeted radiotherapeutics for central nervous system cancers in adults and children. Its lead candidate, REYOBIQ, is being studied in multicenter ReSPECT trials for recurrent glioblastoma, leptomeningeal metastases, and pediatric brain tumors. The business is headquartered in Houston, Texas, and operates in the radiopharmaceutical and diagnostic space addressing CNS malignancies.

In 2026, Plus Therapeutics announced a manufacturing collaboration with SpectronRx to support late-stage clinical manufacturing of Rhenium-186 and REYOBIQ. The company has expanded its leadership and program activity, including appointing a Chief Development Officer to advance development efforts. With a relatively small team, the organization concentrates on CNS-focused diagnostics and radiopharmaceuticals.

Most Common Email Formats at Plus Therapeutics, Inc.

Frequently Asked Questions

What does Plus Therapeutics, Inc. do?

What is Plus Therapeutics, Inc.'s email address format?

How many employees does Plus Therapeutics, Inc. have currently?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Plus Therapeutics, Inc. Email Format

Verify Plus Therapeutics, Inc. email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Most Common Email Formats at Plus Therapeutics, Inc.

Frequently Asked Questions

What does Plus Therapeutics, Inc. do?

What is Plus Therapeutics, Inc.'s email address format?

How many employees does Plus Therapeutics, Inc. have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Plus Therapeutics, Inc. Email Format

Verify Plus Therapeutics, Inc. email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.